Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Fabio, Ynoe de Moraes"'
Autor:
Stephane Thibodeau, Paul Nguyen, Andrew Robinson, Fabio Ynoe de Moraes, Jason Pantarotto, Timothy P. Hanna
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 50, Iss , Pp 100873- (2025)
Purpose: Stage III non-small cell lung cancer (NSCLC) is a heterogeneous disease, with a spectrum of anatomic extent, health status, and treatment approaches. Receipt of treatment and its intent should be independent of health system factors where ca
Externí odkaz:
https://doaj.org/article/9e73c446f3e842dc97e8a497fd3cc1e7
Autor:
Leandro Luongo Matos, Luiz Paulo Kowalski, Aline Lauda Freitas Chaves, Thiago Bueno de Oliveira, Gustavo Nader Marta, Maria Paula Curado, Gilberto de Castro Junior, Terence P. Farias, Gustavo Sarria Bardales, Mario Avila Cabrera, Renato de Castro Capuzzo, Genival Barbosa de Carvalho, Claudio Roberto Cernea, Rogério Aparecido Dedivitis, Fernando Luiz Dias, Andrés Munyo Estefan, Agustin Horacio Falco, Gustavo Alberto Ferraris, Alejandro Gonzalez-Motta, Andre Guimarães Gouveia, Alexandre Arthur Jacinto, Marco Aurelio Vamondes Kulcsar, Ana Kober Leite, Renan Bezerra Lira, Milena Perez Mak, Pedro De Marchi, Evandro Sobroza de Mello, Fátima Cristina Mendes de Matos, Pablo H. Montero, Eduardo Dias de Moraes, Fabio Ynoe de Moraes, Diego Chaves Rezende Morais, Fernando Miguel Poenitz, Adela Poitevin, Hernán Ortiz Riveros, Álvaro Sanabria, Miguel Ticona-Castro, José Guilherme Vartanian, Gustavo Viani, Eugenio F. Vines, William Nassib William Junior, David Conway, Shama Virani, Paul Brennan
Publikováno v:
JCO Global Oncology, Vol , Iss 10 (2024)
Head and neck squamous cell carcinoma (HNSCC) is well known as a serious health problem worldwide, especially in low-income countries or those with limited resources, such as most countries in Latin America. International guidelines cannot always be
Externí odkaz:
https://doaj.org/article/f28cb052e49f4b96b49e705752ebdf3f
Autor:
Stephane Thibodeau, Mahbuba Meem, Wilma Hopman, Simran Sandhu, Osbert Zalay, Andrea S. Fung, Adi Kartolo, Geneviève C. Digby, Shahad Al-Ghamdi, Andrew Robinson, Allison Ashworth, Timothy Owen, Aamer Mahmud, Kit Tam, Timothy Olding, Fabio Ynoe de Moraes
Publikováno v:
Cancer Treatment and Research Communications, Vol 36, Iss , Pp 100747- (2023)
Purpose/Objective: Around 30% of patients with non-small cell lung cancers (NSCLC) are diagnosed with stage III disease at presentation, of which about 50% are treated with definitive chemoradiation (CRT). Around 65–80% of patients will eventually
Externí odkaz:
https://doaj.org/article/3d8d681f93cc4264a88179a2b79a4362
Autor:
Archita Srivastava, Matthew Jalink, Fabio Ynoe de Moraes, Christopher M. Booth, Scott R. Berry, Fidel Rubagumya, Felipe Roitberg, Manju Sengar, Nazik Hammad
Publikováno v:
JCO Global Oncology, Vol , Iss 7, Pp 925-933 (2021)
Existing literature has described the projected increase in cancer incidence and the associated deficiencies in the cancer workforce. However, there is currently a lack of research into the necessary policy and planning steps that can be taken to mit
Externí odkaz:
https://doaj.org/article/0fcc476a3f584602bacde1dce7d8c5e7
Autor:
Derek S. Tsang, MD, MSc, Mohammad M. Khandwala, MD, Zhihui Amy Liu, PhD, Nadine Richard, PhD, Gerald Shen, HBSc, Angela Sekely, MA, Lori J. Bernstein, PhD, Rebecca Simpson, Warren Mason, MD, Caroline Chung, MD, MSc, Fabio Ynoe de Moraes, MD, PhD, Louise Murray, MBChB, PhD, David Shultz, MD, PhD, Normand Laperriere, MD, Barbara-Ann Millar, MBChB, Kim Edelstein, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 6, Pp 101028- (2022)
Purpose: The contributory effects of radiation dose to different brain regions on neurocognitive performance after radiation therapy (RT) for primary brain tumors is not well known. Methods and Materials: In this retrospective cohort study, 30 patien
Externí odkaz:
https://doaj.org/article/afd7b90898fe4123aaa31c37b07ddf17
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Externí odkaz:
https://doaj.org/article/9ca555b68da44e4db586f97bd10de91c
Autor:
Karanbir Brar, Laureen D. Hachem, Jetan H. Badhiwala, Christine Mau, Brad E. Zacharia, Fabio Ynoe de Moraes, Farhad Pirouzmand, Alireza Mansouri
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
The surgical management of diffuse low-grade gliomas (DLGGs) has undergone a paradigm shift toward striving for maximal safe resection when feasible. While extensive observational data supports this transition, unbiased evidence in the form of high q
Externí odkaz:
https://doaj.org/article/9164110be3204a8a835510545a99eebc
Autor:
Brooke E, Wilson, Andrew, Oar, Danielle, Rodin, Freddie, Bray, Jacques, Ferlay, Alfredo, Polo, Josep M, Borras, Jean-Marc, Bourque, Monica, Malik, Fabio, Ynoe de Moraes, Yolande, Lievens, Lisa M, Stevens, Eduardo, Zubizarreta, Mei Ling, Yap
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Universidad de Barcelona
Background: In 2015, the Global Task Force on Radiotherapy for Cancer Control (GTFRCC) called for 80% of National Cancer Control Plans (NCCP) to include radiotherapy by 2020. As part of the ongoing ESTRO Global Impact of Radiotherapy in Oncology (GIR
Autor:
Michela Febbraro, Atish Gheware, Thomas Kennedy, Deepali Jain, Fabio Ynoe de Moraes, Rosalyn Juergens
Publikováno v:
American Society of Clinical Oncology Educational Book. :666-672
Globally, lung cancer is the second most-diagnosed cancer and is the leading cause of cancer death. Advances in science and technology have contributed to improvements in primary cancer prevention, cancer diagnosis, and cancer therapy, leading to an
Autor:
Rafael Gadia, MD, Elton Trigo Teixeira Leite, MD, Ana Luiza Bierrenbach, PhD, Fabio Ynoe de Moraes, MD, Daniel E. Spratt, MD, Fernando Freire Arruda, MD, Carlos Eduardo Cintra Vita Abreu, MD, Joao Luis Fernandes da Silva, MD, Heloisa de Andrade Carvalho, PhD, Bernardo Garicochea, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 1, Iss 4, Pp 300-309 (2016)
Objective: The addition of androgen deprivation therapy (ADT) to conventional radiation therapy improves overall survival (OS) in intermediate- and high-risk prostate cancer. The benefit of ADT to added to dose-escalated radiotherapy is less clear. T
Externí odkaz:
https://doaj.org/article/324c5941a8f74f61bea0999b6dab30a5